Cardiovascular disease is the leading cause of death in women in the UK, accounting for more deaths than all cancers combined. Yet public perception continues to frame heart disease primarily as a male condition. The menopause is a significant inflection point in women's cardiovascular trajectory. Before the menopause, women have substantially lower cardiovascular event rates than age-matched men, partly due to the cardioprotective effects of oestrogen. After the menopause, this protective differential narrows and eventually disappears. By age 75, the cardiovascular event rates of men and women have equalised.
What Oestrogen Does for the Heart
Oestrogen has multiple direct cardioprotective effects. It promotes endothelial nitric oxide production, maintaining vascular flexibility and reducing arterial stiffness. It has anti-inflammatory effects on the vascular wall, reducing the oxidation of LDL cholesterol that initiates atherosclerotic plaque formation. It maintains favourable lipid profiles by reducing LDL and increasing HDL cholesterol. And it reduces fibrinogen and other clotting factors, lowering thrombotic risk. When oestrogen declines at the menopause, all of these protective mechanisms diminish simultaneously.
The Lipid Shift at Menopause
LDL cholesterol rises on average by 10 to 15 percent in the first two years following the final menstrual period, independent of dietary changes or weight gain. HDL cholesterol falls. Triglycerides rise. Small dense LDL particles, the most atherogenic fraction, increase disproportionately. These lipid changes substantially increase 10-year cardiovascular risk in postmenopausal women and warrant active monitoring. Many women who have always had healthy lipids find that their first elevated cholesterol result comes in the years immediately following the menopause.
Prevention: Lifestyle and HRT
The cardiovascular prevention evidence for menopausal women includes both lifestyle interventions and, for appropriately selected women, HRT. Regular aerobic exercise maintains endothelial function, HDL levels, and reduces cardiovascular risk independent of weight. A Mediterranean-style diet pattern reduces LDL oxidation and systemic inflammation. HRT started within 10 years of the menopause, the timing hypothesis, appears to be cardioprotective rather than harmful in this population, consistent with oestrogen's vascular mechanisms. The apparent cardiovascular risk seen in the WHI was confined to women initiating HRT more than 10 years after the menopause, when pre-existing atherosclerosis had already developed.
- Request a fasting lipid panel at the menopause and annually thereafter: the lipid shift may require active management
- Undertake 150 minutes of moderate aerobic exercise weekly as the primary cardiovascular intervention
- Adopt a Mediterranean dietary pattern: olive oil, vegetables, fish, legumes, and whole grains are evidence-based for cardiovascular risk reduction
- Discuss HRT with your GP in the context of cardiovascular risk, particularly if you have a family history of early heart disease
- Do not smoke: smoking in postmenopausal women without HRT carries a cardiovascular risk substantially higher than either factor alone
Sources
- Rossouw, J.E., et al. (2002, and reanalyses). Risks and benefits of oestrogen plus progestin in healthy postmenopausal women. JAMA, 288(3), 321-333.
- Matthews, K.A., et al. (2001). Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology, 37(5), 1366-1373.